With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – Among women with a singleton pregnancy, prior preterm birth, and a short cervix, cerclage significantly reduces the risk of another preterm delivery, as…
NEW YORK (Reuters Health) – Retropubic or transobturator placement of tension-free vaginal tape are both effective techniques for reducing stress urinary incontinence in women. However, leg or groin…
NEW YORK (Reuters Health) – New research from Japan suggests that antenatal corticosteroids promote survival in extremely preterm infants born at 22 to 23 weeks gestation. Based on…
NEW YORK (Reuters Health) – Clinical outcomes are no better or worse when nulliparous women with an unfavorable cervix at term have elective induction of labor compared to…
NEW YORK (Reuters Health) – Wound complications occur twice as often when transverse cesarean sections are closed with staples rather than subcuticular sutures, the results of a meta-analysis…
NEW YORK (Reuters Health) – Methylene blue has certain advantages over isosulfan blue in sentinel lymph node procedures, but the risk of a palpable mass at the injection…
NEW YORK (Reuters Health) – Women undergoing emetogenic surgical procedures are less likely to have postoperative nausea and vomiting when treated with ondansetron plus casopitant than with ondansetron…
NEW YORK (Reuters Health) – The majority of women who become pregnant after in vitro fertilization (IVF) receives progesterone throughout the first trimester, but that may not be…
NEW YORK (Reuters Health) – Among women treated for early, endocrine-responsive breast cancer, adjuvant therapy with the aromatase inhibitor letrozole leads to better overall survival than does tamoxifen,…
NEW YORK (Reuters Health) – Oral contraceptives are just as effective as a gonadotropin-releasing hormone (GnRH) agonist for relieving pelvic pain due to endometriosis, results of a small…
